Clinical Trial Update: THE EFFECTS OF GAMBIR CATECHIN (UNCARIA GAMBIR ROXB) SUPPLEMENTATION ON COGNITIVE FUNCTION, EXPRESSION OF APP, MAPT, BDNF, IL-10, TGF-Β GENES, AND PLASMA MDA LEVELS IN THE ELDERLY. [NA]

View source ↗

Summary

A completed clinical trial evaluating whether Gambir catechin supplementation affects cognitive function and expression of APP, MAPT, BDNF, IL-10, TGF-β, and pl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Gambir catechin supplement (catechin extract from Uncaria gambir Roxb)

Snippet

Sponsor: Rahmi Novita Yusuf | Conditions: Elderly Individuals Aged 60 Years or Older, Mild Cognitive Impairment (MCI) | NA | Status: COMPLETED